Peptide May Restore Myelin, Prevent Neuron Death in Multiple Sclerosis

The new peptide did not appear to suppress the immune system, as many MS drugs do.

More than 2.3 million people worldwide are living with multiple sclerosis, a debilitating condition triggered by damage to nerve cells in the central nervous system. But in a new study published in the Annals of Clinical and Translational Neurology, researchers say they may have found a way to reduce this nerve cell damage, paving the way for new treatments for the disease.

Multiple sclerosis (MS) is a progressive neurological disease most commonly diagnosed between the ages of 20 and 50.

While the exact cause of the condition is unclear, it is known to be triggered by an autoimmune response that causes inflammation in the central nervous system.

READ FULL ARTICLE Curated publisher From Medical News Today